Drugmakers to hand back €500m in rebates to Bulgaria’s health budget [Partner Content]
Editorial abstract
The Bulgarian pharmaceutical industry is calling for a 14% funding increase in 2027, warning that the current reimbursement model is becoming increasingly difficult to sustain
This is not the publisher’s original article. Unreviewed abstracts are mechanically condensed from source-provided material; editor-reviewed abstracts have completed editorial review.Story classification
Topics
Economic Policy · High confidence · AutomaticStory-text match
Public Health · High confidence · AutomaticStory-text match
War, Deterrence, and Regional Escalation · High confidence · AutomaticStory-text match
Regions
Europe · High confidence · AutomaticStory-text location match